Halaven OverviewEribulin is an anticancer medication marketed by Eisai Co. under the brand name Halaven. It is used to treat people with breast cancer and liposarcoma. The most common side effects include fatigue, nausea, hair loss (alopecia), constipation, certain nerve damage causing weakness or numbness in the hands and feet (peripheral neuropathy), abdominal pain and fever (pyrexia). Eribulin may also cause low levels of infection-fighting white bl...
Read more Halaven Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Eribulin
Recent Halaven Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Solution: 1mg/2ml (0.5mg/ml)
NDC Database Records for Halaven: (2 results)Sorted by National Drug Code
- 43624-002 Halaven .5 mg/ml Intravenous Injection by Bsp Pharmaceuticals Spa
- 62856-389 Halaven .5 mg/ml Intravenous Injection by Eisai Inc.